Favorable Media Coverage Somewhat Unlikely to Impact Raptor Pharmaceutical Corp (RPTP) Stock Price

Media headlines about Raptor Pharmaceutical Corp (NASDAQ:RPTP) have been trending positive on Tuesday, according to Accern. Accern ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Raptor Pharmaceutical Corp earned a media sentiment score of 0.26 on Accern’s scale. Accern also assigned headlines about the biotechnology company an impact score of 46.4491738886128 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Shares of Raptor Pharmaceutical Corp (NASDAQ RPTP) remained flat at $9.00 during trading on Tuesday.

ILLEGAL ACTIVITY NOTICE: “Favorable Media Coverage Somewhat Unlikely to Impact Raptor Pharmaceutical Corp (RPTP) Stock Price” was originally posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.themarketsdaily.com/2017/08/08/positive-media-coverage-somewhat-unlikely-to-impact-raptor-pharmaceutical-corp-rptp-share-price-updated.html.

About Raptor Pharmaceutical Corp

Raptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years.

Receive News & Ratings for Raptor Pharmaceutical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raptor Pharmaceutical Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply